Interacting Drugs |
Methylergonovine vs Protease Inhibitors |
Security Level |
 |
Mechanism |
Protease Inhibitors: May increase the serum concentration of Ergot Derivatives. |
Management |
Avoid combination |
Methylergonovine vs Protease Inhibitors
Post Review about Methylergonovine vs Protease Inhibitors Click here to cancel reply.
Other Interactions of Methylergonovine
Other Interactions of Protease Inhibitors
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.